184 related articles for article (PubMed ID: 11280774)
1. SMAD3 represses androgen receptor-mediated transcription.
Hayes SA; Zarnegar M; Sharma M; Yang F; Peehl DM; ten Dijke P; Sun Z
Cancer Res; 2001 Mar; 61(5):2112-8. PubMed ID: 11280774
[TBL] [Abstract][Full Text] [Related]
2. From transforming growth factor-beta signaling to androgen action: identification of Smad3 as an androgen receptor coregulator in prostate cancer cells.
Kang HY; Lin HK; Hu YC; Yeh S; Huang KE; Chang C
Proc Natl Acad Sci U S A; 2001 Mar; 98(6):3018-23. PubMed ID: 11248024
[TBL] [Abstract][Full Text] [Related]
3. The androgen receptor represses transforming growth factor-beta signaling through interaction with Smad3.
Chipuk JE; Cornelius SC; Pultz NJ; Jorgensen JS; Bonham MJ; Kim SJ; Danielpour D
J Biol Chem; 2002 Jan; 277(2):1240-8. PubMed ID: 11707452
[TBL] [Abstract][Full Text] [Related]
4. TGF-beta signaling and androgen receptor status determine apoptotic cross-talk in human prostate cancer cells.
Zhu ML; Partin JV; Bruckheimer EM; Strup SE; Kyprianou N
Prostate; 2008 Feb; 68(3):287-95. PubMed ID: 18163430
[TBL] [Abstract][Full Text] [Related]
5. Cross-talk between the Notch and TGF-beta signaling pathways mediated by interaction of the Notch intracellular domain with Smad3.
Blokzijl A; Dahlqvist C; Reissmann E; Falk A; Moliner A; Lendahl U; Ibáñez CF
J Cell Biol; 2003 Nov; 163(4):723-8. PubMed ID: 14638857
[TBL] [Abstract][Full Text] [Related]
6. TGF-beta inhibits muscle differentiation through functional repression of myogenic transcription factors by Smad3.
Liu D; Black BL; Derynck R
Genes Dev; 2001 Nov; 15(22):2950-66. PubMed ID: 11711431
[TBL] [Abstract][Full Text] [Related]
7. Roles for lysine residues of the MH2 domain of Smad3 in transforming growth factor-beta signaling.
Imoto S; Sugiyama K; Sekine Y; Matsuda T
FEBS Lett; 2005 May; 579(13):2853-62. PubMed ID: 15907489
[TBL] [Abstract][Full Text] [Related]
8. DHT selectively reverses Smad3-mediated/TGF-beta-induced responses through transcriptional down-regulation of Smad3 in prostate epithelial cells.
Song K; Wang H; Krebs TL; Wang B; Kelley TJ; Danielpour D
Mol Endocrinol; 2010 Oct; 24(10):2019-29. PubMed ID: 20739403
[TBL] [Abstract][Full Text] [Related]
9. Repression of Smad-dependent transforming growth factor-beta signaling by Epstein-Barr virus latent membrane protein 1 through nuclear factor-kappaB.
Mori N; Morishita M; Tsukazaki T; Yamamoto N
Int J Cancer; 2003 Jul; 105(5):661-8. PubMed ID: 12740915
[TBL] [Abstract][Full Text] [Related]
10. Differential modulation of androgen receptor-mediated transactivation by Smad3 and tumor suppressor Smad4.
Kang HY; Huang KE; Chang SY; Ma WL; Lin WJ; Chang C
J Biol Chem; 2002 Nov; 277(46):43749-56. PubMed ID: 12226080
[TBL] [Abstract][Full Text] [Related]
11. The transforming growth factor-beta/SMAD signaling pathway is present and functional in human mesangial cells.
Poncelet AC; de Caestecker MP; Schnaper HW
Kidney Int; 1999 Oct; 56(4):1354-65. PubMed ID: 10504488
[TBL] [Abstract][Full Text] [Related]
12. Interaction between Smad anchor for receptor activation and Smad3 is not essential for TGF-beta/Smad3-mediated signaling.
Goto D; Nakajima H; Mori Y; Kurasawa K; Kitamura N; Iwamoto I
Biochem Biophys Res Commun; 2001 Mar; 281(5):1100-5. PubMed ID: 11243848
[TBL] [Abstract][Full Text] [Related]
13. Axin facilitates Smad3 activation in the transforming growth factor beta signaling pathway.
Furuhashi M; Yagi K; Yamamoto H; Furukawa Y; Shimada S; Nakamura Y; Kikuchi A; Miyazono K; Kato M
Mol Cell Biol; 2001 Aug; 21(15):5132-41. PubMed ID: 11438668
[TBL] [Abstract][Full Text] [Related]
14. Novel function of androgen receptor-associated protein 55/Hic-5 as a negative regulator of Smad3 signaling.
Wang H; Song K; Sponseller TL; Danielpour D
J Biol Chem; 2005 Feb; 280(7):5154-62. PubMed ID: 15561701
[TBL] [Abstract][Full Text] [Related]
15. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
16. Interaction of smad3 with a proximal smad-binding element of the human alpha2(I) procollagen gene promoter required for transcriptional activation by TGF-beta.
Chen SJ; Yuan W; Lo S; Trojanowska M; Varga J
J Cell Physiol; 2000 Jun; 183(3):381-92. PubMed ID: 10797313
[TBL] [Abstract][Full Text] [Related]
17. Smad3/AP-1 interactions control transcriptional responses to TGF-beta in a promoter-specific manner.
Verrecchia F; Vindevoghel L; Lechleider RJ; Uitto J; Roberts AB; Mauviel A
Oncogene; 2001 Jun; 20(26):3332-40. PubMed ID: 11423983
[TBL] [Abstract][Full Text] [Related]
18. Physical and functional interaction between GATA-3 and Smad3 allows TGF-beta regulation of GATA target genes.
Blokzijl A; ten Dijke P; Ibáñez CF
Curr Biol; 2002 Jan; 12(1):35-45. PubMed ID: 11790301
[TBL] [Abstract][Full Text] [Related]
19. Smad3 and Smad4 cooperate with c-Jun/c-Fos to mediate TGF-beta-induced transcription.
Zhang Y; Feng XH; Derynck R
Nature; 1998 Aug; 394(6696):909-13. PubMed ID: 9732876
[TBL] [Abstract][Full Text] [Related]
20. Beta-hydroxybutyrate-induced growth inhibition and collagen production in HK-2 cells are dependent on TGF-beta and Smad3.
Guh JY; Chuang TD; Chen HC; Hung WC; Lai YH; Shin SJ; Chuang LY
Kidney Int; 2003 Dec; 64(6):2041-51. PubMed ID: 14633126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
